Chemotherapy
Research findings from E. Mellado et al update understanding of chemotherapy
Published in Proteomics Weekly, September 3rd, 2007
"Fourteen Aspergillus fumigatus clinical isolates that exhibited a pattern of reduced susceptibility to triazole drugs were analyzed. The sequences of the cyp51A gene from all isolates showed the presence of a point mutation at t364a, which led to the substitution of leucine 98 for histidine (L98H), together with the presence of two copies of a 34-bp sequence in tandem in the promoter of the cyp51A gene," researchers in Madrid, Spain report.
"Quantitative expression analysis (real-time PCR) showed up to an eightfold increase in the level of expression of the cyp51A gene compared to that by the susceptible strain. Three PCR fragments of one azole-resistant strain (strain...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Proteomics Weekly
Source: Proteomics Weekly (2007-09-03)
More Articles from Proteomics Weekly
- Delirium
'Alzheimer's Gene' Linked to Increased Risk of Postoperative Delirium - DNA Research
Clemson chemists discover new way antioxidants fight debilitating diseases - Aging
Jan Marini Skin Research Announces Revolutionary Anti-Aging Technology - Age Intervention Regeneration Booster - Bioengineering
Adnexus Therapeutics to Present Data on Adnectin Product Candidate, CT-322, at Gordon Research Conference - Bioengineering
Demand for DNA Repair Formula Drives Growth of Remergent Brand - Bioengineering
Sony Computer Entertainment America Announces New Features and Enhancements for PlayStation3 Folding@Home Application - More from this issue of Proteomics Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
